Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Carmell Therapeutics Corp...

    NASDAQ: CTCX · Real-Time Price · USD
    0.20
    0.01 (2.77%)
    At close: Mar 07, 2025, 3:55 PM

    Carmell Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 124.79K 242.56K n/a
    Gross Profit
    		 -124.79K -242.56K n/a
    Operating Income
    		 -5.22M -5.51M -1.94M
    Interest Income
    		 n/a 2.25M 8.09K
    Pretax Income
    		 -16.21M -9.05M -6.48M
    Net Income
    		 -15.45M -9.05M -6.48M
    Selling & General & Admin
    		 2.6M 3.22M 863.33K
    Research & Development
    		 2.5M 2.2M 982.84K
    Other Expenses
    		 n/a 10.92K 37.38K
    Operating Expenses
    		 5.09M 5.51M 1.94M
    Interest Expense
    		 889.32K 3.75M 2.5M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 5.22M 5.51M 1.94M
    Income Tax Expense
    		 -760.16K 391.2K 2.54M
    Shares Outstanding (Basic)
    		 11.02M 19.77M 19.77M
    Shares Outstanding (Diluted)
    		 11.02M 19.77M 19.77M
    EPS (Basic)
    		 -1.46 -0.46 -0.33
    EPS (Diluted)
    		 -1.46 -0.46 -0.33
    EBITDA
    		 -15.19M -5.25M -1.66M
    EBIT
    		 -15.32M -5.3M -329.38K
    Depreciation & Amortization
    		 124.79K 242.56K 242.12K

    Add to Watchlist